OPTIMAPHARM
DEAD

Serial Number

79285462

Owner

OPTIMAPHARM d.d.

Attorney

James N Palik

Filing Date

Feb 7, 2020

Add to watchlist:

No watchlists yet
View on USPTO

OPTIMAPHARM Trademark

Serial Number: 79285462

OPTIMAPHARM is a trademark filed by OPTIMAPHARM d.d. on February 7, 2020. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

OPTIMAPHARM d.d.

Ulica grada Vukovara 284

Entity Type: 09

Trademark Details

Filing Date

February 7, 2020

Registration Date

Not Registered

Goods & Services

Electronic publishing services, namely, publication of text and graphic works of others on recorded media and on-line featuring medical research publication of books; publication of texts, other than publicity texts; providing online publications in the nature of electronic books and journals in the field of diseases and medical and pharmaceutical research providing online electronic publications, not downloadable in the nature of diseases and medical and pharmaceutical in the field of diseases and medical and pharmaceutical research; news reporters services

Corporate communications services, namely, providing consultation regarding public relations communication strategies to businesses; organization of exhibitions for commercial or advertising purposes; organization of trade fairs; distribution of samples, advertising by mail order, rental of advertising time on communication media; wholesale store services for pharmaceutical, veterinary and medical preparations and supplies, retail store and wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; drawing up of statements of accounts, namely, preparation of financial statements; business auditing, compilation of information into computer databases, systemization of information into computer databases; psychological testing for the selection of personnel; human resources consultancy, personnel recruitment; billing; updating and maintenance of data in computer databases; photocopying services; appointment scheduling services [office functions], business management consultancy, business management and organization consultancy, business organization consultancy, professional business consultancy, advisory services for business management; rental of office machines and equipment

Technical writing; data security consultancy; research and development of new products for others; technical research in the field of pharmaceutical studies, conducting clinical trials for others [conducting], research related to pharmaceuticals, research on the subject of pharmaceuticals, research and development for the pharmaceutical industry, research and development in the pharmaceutical and biotechnology fields, clinical research in the field of hematology, oncology, cardiovascular diseases and disorders, metabolic disorders, diabetes, endocrinology, gastro-intestinal diseases and disorders, hepatic and biliary diseases and disorders, hiv and related conditions, immunology, infectious diseases, musculoskeletal diseases and disorders, neurology, psychiatry, reproduction, respiratory diseases and disorders, sensory organs, dermatology, surgery and surgical procedures, urinary tract diseases and disorders consultancy relating to research and development in the field of therapeutics, consultancy relating to laboratory testing, consultancy in the field of pharmaceutical research, calibration services relating to medical apparatus, research and development of vaccines and medicines, pharmaceutical products research, testing of pharmaceuticals, consultancy relating to pharmacology, pharmaceutical drug development services, biological research, clinical and medical research in the field of hematology, oncology, cardiovascular diseases and disorders, metabolic disorders, diabetes, endocrinology, gastro-intestinal diseases and disorders, hepatic and biliary diseases and disorders, hiv and related conditions, immunology, infectious diseases, musculoskeletal diseases and disorders, neurology, psychiatry, reproduction, respiratory diseases and disorders, sensory organs, dermatology, surgery and surgical procedures, urinary tract diseases and disorders, medical research, conducting early evaluations in the field of new pharmaceuticals, pharmaceutical product evaluation, conducting clinical trials for others for pharmaceutical products, conducting clinical trials for others in the field of cardiovascular disease, conducting clinical trials for others, provision of information and data relating to medical and veterinary research and development, providing information about the results of clinical trials for pharmaceutical products, providing medical and scientific research information in the field of pharmaceuticals and clinical trials, providing scientific information in the field of medical disorders and their treatment, development of pharmaceutical preparations and medicines, pharmaceutical products development

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 29, 2022 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Aug 11, 2022 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 11, 2022 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 8, 2021 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 20, 2021 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 20, 2021 OPNR
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Aug 11, 2021 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Aug 11, 2021 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 25, 2021 GNFN
FINAL REFUSAL E-MAILED
Jan 25, 2021 GNFR
FINAL REFUSAL WRITTEN
Jan 25, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 29, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 29, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 29, 2020 TROA
REFUSAL PROCESSED BY IB
Jul 18, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 30, 2020 RFCS
REFUSAL PROCESSED BY MPU
Jun 30, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 28, 2020 RFCR
NON-FINAL ACTION WRITTEN
May 27, 2020 CNRT
APPLICATION FILING RECEIPT MAILED
May 19, 2020 MAFR
ASSIGNED TO EXAMINER
May 15, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 15, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 14, 2020 REPR